[Objective]Observed Wenxinkeli combined effect of propafenone treatment of atrial fibrillation.[Methods]Using randomized controlled method,56 cases of outpatients were randomly divided into two groups randomly.Control group,28 cases of small doses of propafenone,100mg / time,3 times / d.Treatment group 28 cases Wenxinkeli,composition Dangshen,Huang Jing,Sanqi,Hupo,Gansong,etc.oral,9g / time,3 times / d.Western medicine with the control group,and propafenone with delivery service.28d is a course of continuous treatment.Observation of clinical symptoms,atrial fibrillation effects,adverse reactions.Continuous treatment of a course of treatment(28d),to determine efficacy.[Results]treatment group,18 cases markedly effective in 8 cases,2 cases,the total efficiency of 92.90%.Control group,13 cases were markedly effective in 7 cases,8 cases,the total efficiency of 71.40%.Treatment group than the control group(P <0.05).After 24h Holter Holter compare the efficacy of atrial fibrillation treatment group than the control group(P <0.05)[.Conclusion] Wenxinkeli propafenone treatment of atrial fibrillation combined effect is significant,drug side effects,worthy of promotion.

目的 探讨中药烫熨法在社区胃炎患者疼痛治疗中的临床疗效.方法 选取2010年3月-2012年12月期间到我院进行胃炎疼痛治疗的患者80例,随机分成对照组和观察组,每组患者40例,对照组患者使用奥美拉唑(口服20mg,一天两次)治疗7天,观察组患者则使用中药烫熨法治疗7天,比较两组患者的临床疗效.结果 经治疗后,对照组患者的治疗有效率为72.5％,观察组患者的治疗有效率为90.0％.观察组患者的治疗效果明显优于对照组,两组差异有统计学意义(p＜0.05).结论 中药烫熨疗法可以有效患者胃炎患者的疼痛症状,明显改善患者的生活质量,值得在社区医院推广应用.

Objective To observe the community intervention effect of patients with chronic obstructive pulmonary disease(COPD).Methods 54 patients with COPD from my hospital were selected,which were given community intervention.The self-conscious symptom scores,the number of acute episodes,6 min walking distance,the number of colds before and after intervention were compared.Results The self-conscious symptom scores,the number of acute attack,the number of colds after treatment less than those befre treatment,6 min walking distance after treatment increased than those befre treatment(P < 0.01).Conclusion Through community intervention in COPD patients,diseases are well controlled,the quality of life is enhancing.

目的探讨稳心颗粒联合普罗帕酮治疗心房颤动的临床效果。方法选择2012年1月—2013年2月治疗的心房颤动患者56例,随机分为对照组和实验组各28例,对照组给予普罗帕酮口服,每次100 mg,3次/d。实验组在对照组基础上加稳心颗粒口服,每次9 g,3次/d。两组均持续治疗4周观察临床症状和心房颤动改善情况。计数资料采用χ2检验,P<0.05为差异有统计学意义。结果两组临床症状改善情况总有效率对照组71.4%,实验组92.9%,两组比较差异有统计学意义(χ2=4.38,P<0.05)。两组心房颤动改善情况总有效率对照组64.3%,实验组89.3%,两组比较差异有统计学意义(χ2=4.91,P<0.05)。对照组胃部不适3例,轻度头昏2例;实验组传导阻滞3例,窦性心动过缓2例,食欲下降1例。以上不良反应不影响实验效果。结论稳心颗粒联合普罗帕酮治疗心房颤动效果显著,并且不良反应小,适合临床推广。